Jun Shen-Jun
160# Pu Jian Ave
Shanghai, 200127, China
Shanghai, 200127, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: July 01, 2026
Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: March 22, 2026
Infliximab response associates with radiologic findings in bio-naïve Crohn's disease.
Journal: European radiology
Published: June 09, 2022
Mucosal immunity and tRNA, tRF, and tiRNA.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: September 16, 2020
Development of a clinical model to predict secondary non-response of infliximab treatment in Crohn's disease.
Journal: International journal of colorectal disease
Published: June 17, 2020
Role of environmental factors in the pathogenesis of Crohn's disease: a critical review.
Journal: International journal of colorectal disease
Published: October 21, 2019
Expression and regulation of long noncoding RNAs in TLR4 signaling in mouse macrophages.
Journal: BMC genomics
Published: July 26, 2014
Utility of the diffusion-weighted imaging for activity evaluation in Crohn's disease patients underwent magnetic resonance enterography.
Journal: BMC gastroenterology
Published: July 16, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026